Harel Insurance Investments & Financial Services Ltd. Editas Medicine, Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 Apr 27, 2021	SELL	$39.71 - $90.58 $158,840 - $362,320	-4,000 Closed	0 $0
Q4 2020 Jan 26, 2021	BUY	$27.07 - $84.35 $108,280 - $337,400	4,000 New	4,000 $902,000

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$17.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$14.8 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$10.8 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$7.41 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$5.44 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $152M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account